Literature DB >> 11458541

Regulation of opioid receptors by cocaine.

E M Unterwald1.   

Abstract

Cocaine is a widely abused psychostimulant. Its direct actions include inhibition of dopamine, serotonin, and norepinephrine reuptake into presynaptic nerve terminals, thereby potentiating the actions of these transmitters in the synapse. A variety of studies have demonstrated that cocaine can also have profound effects on the endogenous opioid system. Compelling evidence points to the importance of mu opioid receptors in human cocaine addiction and craving. Animal studies support these findings and demonstrate that chronic cocaine administration can result in alterations in opioid receptor expression and function as measured by changes in critical signal transduction pathways. This chapter reviews studies on the regulation of opioid receptors as the result of exposure to cocaine.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11458541     DOI: 10.1111/j.1749-6632.2001.tb03559.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  14 in total

1.  Exposure to cocaine alters dynorphin-mediated regulation of excitatory synaptic transmission in nucleus accumbens neurons.

Authors:  Ping Mu; Peter A Neumann; Jaak Panksepp; Oliver M Schlüter; Yan Dong
Journal:  Biol Psychiatry       Date:  2010-10-27       Impact factor: 13.382

2.  Regulation of dynamin 2 and G protein-coupled receptor kinase 2 in rat nucleus accumbens during acute and repeated cocaine administration.

Authors:  Joseph A Schroeder; Mary R McCafferty; Ellen M Unterwald
Journal:  Synapse       Date:  2009-10       Impact factor: 2.562

Review 3.  The endogenous opioid system in cocaine addiction: what lessons have opioid peptide and receptor knockout mice taught us?

Authors:  Ji Hoon Yoo; Ian Kitchen; Alexis Bailey
Journal:  Br J Pharmacol       Date:  2012-08       Impact factor: 8.739

4.  Differential response to IV carfentanil in chronic cocaine users and healthy controls.

Authors:  Carolynne P Minkowski; David Epstein; J James Frost; David A Gorelick
Journal:  Addict Biol       Date:  2010-11-04       Impact factor: 4.280

5.  Brain mu-opioid receptor binding predicts treatment outcome in cocaine-abusing outpatients.

Authors:  Udi E Ghitza; Kenzie L Preston; David H Epstein; Hiroto Kuwabara; Christopher J Endres; Badreddine Bencherif; Susan J Boyd; Marc L Copersino; J James Frost; David A Gorelick
Journal:  Biol Psychiatry       Date:  2010-07-01       Impact factor: 13.382

6.  Treatment-like steady-state methadone in rats interferes with incubation of cocaine sensitization and associated alterations in gene expression.

Authors:  Francesco Leri; Yan Zhou; Brendan Carmichael; Erin Cummins; Mary Jeanne Kreek
Journal:  Eur Neuropsychopharmacol       Date:  2011-07-13       Impact factor: 4.600

7.  Placebo effects mediated by endogenous opioid activity on mu-opioid receptors.

Authors:  Jon-Kar Zubieta; Joshua A Bueller; Lisa R Jackson; David J Scott; Yanjun Xu; Robert A Koeppe; Thomas E Nichols; Christian S Stohler
Journal:  J Neurosci       Date:  2005-08-24       Impact factor: 6.167

8.  Steady-state methadone blocks cocaine seeking and cocaine-induced gene expression alterations in the rat brain.

Authors:  Francesco Leri; Yan Zhou; Benjamin Goddard; AnneMarie Levy; Derek Jacklin; Mary Jeanne Kreek
Journal:  Eur Neuropsychopharmacol       Date:  2008-11-06       Impact factor: 4.600

9.  Differential time course of effects of kappa-opioid agonist treatment on dynorphin A levels and kappa-opioid receptor density.

Authors:  Claudio D'Addario; Manuela Di Benedetto; Sari Izenwasser; Sanzio Candeletti; Patrizia Romualdi
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

Review 10.  Evidence for sugar addiction: behavioral and neurochemical effects of intermittent, excessive sugar intake.

Authors:  Nicole M Avena; Pedro Rada; Bartley G Hoebel
Journal:  Neurosci Biobehav Rev       Date:  2007-05-18       Impact factor: 8.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.